127 related articles for article (PubMed ID: 31198311)
1. A Prospective Study on Impact of Early Initiation of Antiretroviral Therapy in Human Immunodeficiency Virus-Positive Adults on Immunological Status and Adverse Events.
Kumar V; Singh J
J Glob Infect Dis; 2019; 11(2):73-79. PubMed ID: 31198311
[TBL] [Abstract][Full Text] [Related]
2. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
3. Study of adverse drug reactions to antiretroviral therapy in a tertiary care hospital, Tirupati.
Rukmangathen R; Brahmanapalli VD; Thammisetty DP; Pemmasani D; Gali SD; Atmakuru RB
Perspect Clin Res; 2020; 11(4):158-163. PubMed ID: 33489833
[TBL] [Abstract][Full Text] [Related]
4. Adverse drug reactions to antiretroviral therapy in AIDS patients at a tertiary care hospital in India: A prospective observational study.
Nagpal M; Tayal V; Kumar S; Gupta U
Indian J Med Sci; 2010 Jun; 64(6):245-52. PubMed ID: 22885315
[TBL] [Abstract][Full Text] [Related]
5. Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.
Mukherjee S; Era N; Saha B; Tripathi SK
Indian J Pharmacol; 2017; 49(3):223-228. PubMed ID: 29033481
[TBL] [Abstract][Full Text] [Related]
6. A safety analysis of different drug regimens used in human immunodeficiency virus-positive patients.
Chauhan NS; Shah SP; Desai MK; Shah A
Indian J Sex Transm Dis AIDS; 2018; 39(2):84-90. PubMed ID: 30623177
[TBL] [Abstract][Full Text] [Related]
7. Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients.
Patel D; Desai M; Shah AN; Dikshit RK
Perspect Clin Res; 2013 Oct; 4(4):215-20. PubMed ID: 24312889
[TBL] [Abstract][Full Text] [Related]
8. A randomized prospective study to assess health-related quality-of-life outcomes of antiretroviral therapy in human immunodeficiency virus-positive adults.
Kumar V; Singh J; Singh H
Indian J Sex Transm Dis AIDS; 2021; 42(1):50-56. PubMed ID: 34765938
[TBL] [Abstract][Full Text] [Related]
9. Adverse Drug Reactions and Prescription Patterns of Antiretroviral Drugs: A Longitudinal Observational Study From a Tertiary Care Hospital in Western India.
Sekar VD; Joshi K; Bhide S; Rao S; Phirke C; Patil S; Kothari R; Patel M; Shankar A
Cureus; 2024 Mar; 16(3):e56424. PubMed ID: 38638708
[TBL] [Abstract][Full Text] [Related]
10. Incidence of adverse drug reactions in human immune deficiency virus-positive patients using highly active antiretroviral therapy.
Srikanth BA; Babu SC; Yadav HN; Jain SK
J Adv Pharm Technol Res; 2012 Jan; 3(1):62-7. PubMed ID: 22470896
[TBL] [Abstract][Full Text] [Related]
11. An assessment of adverse drug reactions among HIV positive patients receiving antiretroviral treatment in South Africa.
Masenyetse LJ; Manda SO; Mwambi HG
AIDS Res Ther; 2015; 12():6. PubMed ID: 25745501
[TBL] [Abstract][Full Text] [Related]
12. Immunological profiling of tuberculosis-associated immune reconstitution inflammatory syndrome and non-immune reconstitution inflammatory syndrome death in HIV-infected adults with pulmonary tuberculosis starting antiretroviral therapy: a prospective observational cohort study.
Ravimohan S; Tamuhla N; Steenhoff AP; Letlhogile R; Nfanyana K; Bellamy SL; MacGregor RR; Gross R; Weissman D; Bisson GP
Lancet Infect Dis; 2015 Apr; 15(4):429-38. PubMed ID: 25672566
[TBL] [Abstract][Full Text] [Related]
13. A randomized prospective study to compare early versus delayed access to antiretroviral therapy over clinical and immunological sequel in HIV-positive adults.
Kumar V; Sharma A; Singh J; Singh H
J Family Med Prim Care; 2022 Nov; 11(11):6959-6969. PubMed ID: 36993137
[TBL] [Abstract][Full Text] [Related]
14. Time to develop adverse drug reactions and associated factors among children HIV positive patients on antiretroviral treatment in North West Amhara Specialized Hospitals: Retrospective cohort study, 2022.
Dagnaw M; Indracanti M; Geremew BM; Mekonnen EA; Tekle M; Muche M; Gelaw DW; Amera BD
Health Sci Rep; 2024 Feb; 7(2):e1933. PubMed ID: 38410498
[TBL] [Abstract][Full Text] [Related]
15. A prospective study to estimate the incidence and pattern of adverse drug reactions to first-line antiretroviral therapy (tenofovir, efavirenz, and lamivudine).
Singh B; Guliani A; Hanumanthu V; Narang T; Dogra S; Handa S; Sharma A
Indian J Sex Transm Dis AIDS; 2023; 44(1):6-10. PubMed ID: 37457534
[TBL] [Abstract][Full Text] [Related]
16. Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women.
Sturt AS; Dokubo EK; Sint TT
Cochrane Database Syst Rev; 2010 Mar; (3):CD008440. PubMed ID: 20238370
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz.
Abah IO; Akanbi M; Abah ME; Finangwai AI; Dady CW; Falang KD; Ebonyi AO; Okopi JA; Agbaji OO; Sagay AS; Okonkwo P; Idoko JA; Kanki PJ
Germs; 2015 Sep; 5(3):83-91. PubMed ID: 26405676
[TBL] [Abstract][Full Text] [Related]
18. Adverse drug reactions in adult medical inpatients in a South African hospital serving a community with a high HIV/AIDS prevalence: prospective observational study.
Mehta U; Durrheim DN; Blockman M; Kredo T; Gounden R; Barnes KI
Br J Clin Pharmacol; 2008 Mar; 65(3):396-406. PubMed ID: 18070223
[TBL] [Abstract][Full Text] [Related]
19. API consensus guidelines for use of antiretroviral therapy in adults (API-ART guidelines). Endorsed by the AIDS Society of India.
Gupta SB; Pujari SN; Joshi SR; Patel AK;
J Assoc Physicians India; 2006 Jan; 54():57-74. PubMed ID: 16649742
[TBL] [Abstract][Full Text] [Related]
20. Adverse drug reactions to antiretroviral therapy (ARVs): incidence, type and risk factors in Nigeria.
Eluwa GI; Badru T; Agu KA; Akpoigbe KJ; Chabikuli O; Hamelmann C
BMC Clin Pharmacol; 2012 Feb; 12():7. PubMed ID: 22369677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
